Divis Laboratories Ltd Share Price Today, Live NSE/BSE Updates

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open-

High-

Low-

Prev. Close-

Avg. Traded Price-

Volume-

MARKET DEPTH

Total bid0.00

Total ask0.00

Orders	Qty	Bid

Ask	Qty	Orders

HIGH/LOW

52w

LOW/HIGH

₹6,611.00a day ago

₹6,720.50a day ago

LOWER/UPPER CIRCUITS

₹6,052.50

₹7,397.50

Divis Laboratories Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Annual Revenue,rose 18.67%, in the last year to ₹9,712 Cr. Its sector's average revenue growth for the last fiscal year was 10.81%.

Annual Net Profit,rose 36.94% in the last year to ₹2,191 Cr. Its sector's average net profit growth for the last fiscal year was 38.61%.

Quarterly Revenue,rose 12.24% YoY to ₹2,671 Cr. Its sector's average revenue growth YoY for the quarter was 11.45%.

LONG-TERM PRICE ANALYSIS

Stock return5Y CAGR : 15.13%

Net profit growth 5Y CAGR : 3.41%

STOCK RETURNS

Versus Nifty 50

1 w

+1.37%

+1.58%

1 mth

+13.08%

+0.87%

3 mth

+18.56%

+11.89%

6 mth

+12.89%

+2.41%

1 yr

+50.91%

+7.8%

3 yr

+90.45%

+55.18%

5 yr

+180.53%

+152.1%

Divis Laboratories Ltd Top mutual funds holding

360 ONE Quant Fund-Reg(G)

3Y Return+29.9%

NAV₹19.35

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

3Y Return+29.8%

NAV₹39.37

Similar stocks

SUNPHARMA₹1,687.80+0.40 (0.02%)

CIPLA₹1,505.20+2.40 (0.16%)

DRREDDY₹1,362.50-0.20 (0.01%)

TORNTPHARM₹3,252.50-6.30 (0.19%)

MANKIND₹2,381.30-8.70 (0.36%)

Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world. The company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.

Grow your wealth with more research recommendations

+91

We're all set for a new experience. To visit the old Ventura website, click here.

Ventura Wealth Clients Login here